Muco Rhinathiol Enfants (Carbocisteine)

Carbocisteine reduces mucus viscosity by cleaving disulfide bonds in mucin proteins, which lowers the molecular weight of the secretions. The thinner mucus can be moved more effectively by ciliary action and coughing, improving clearance from the respiratory tract without suppressing the cough reflex.

The appropriate dose of Muco Rhinathiol Enfants is set by the prescribing healthcare professional based on the child’s age, weight, severity of symptoms, and local prescribing guidelines. Exact dosing instructions should always be taken from the prescriber’s order.

Safety data for carbocisteine in pregnancy are limited, so it should only be used if the potential benefit outweighs any risk and after consulting a healthcare provider. During breastfeeding, caution is advised; the infant should be monitored for any adverse effects.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Carbocisteine, the active ingredient, is a thiol‑based mucolytic that primarily reduces mucus viscosity. Compared with agents such as ambroxol, which also stimulate surfactant production, carbocisteine focuses on breaking disulfide bonds. Both classes improve clearance, but the choice depends on clinical preference, tolerability and local guidelines.

Store the product at room temperature, preferably below 25 °C, in its original packaging. Keep it away from direct sunlight, moisture and heat sources. Ensure the container is tightly closed when not in use to maintain product stability.

The medication is taken orally, usually as a measured dose of the liquid formulation. It should be administered according to the prescriber’s instructions, often using a calibrated dosing device to ensure accurate measurement.

Serious adverse reactions, although rare, include allergic responses such as rash, angioedema, and in very uncommon cases, hepatic enzyme elevations. Any signs of hypersensitivity or severe skin reactions should prompt immediate medical attention.

Children with known hypersensitivity to carbocisteine or any excipients in the formulation should avoid the product. It is also contraindicated in patients where mucolytic therapy is not appropriate, such as those with uncontrolled asthma or severe respiratory obstruction without medical supervision.